Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiace MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Wallace Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimiace MV 1mg/500mg/0.2mg Tablet

Diabetace Control 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Administer Diabetace Control with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and be prepared with a rapid-acting glucose source (e.g., sugary foods, juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual blurring, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests for complete blood count and liver function, will be scheduled by your doctor.

Uses of Glimiace MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimiace MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimiace MV 1mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Glimiace MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimiace MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Glimiace MV 1mg/500mg/0.2mg tablets on an empty stomach.

How Glimiace MV 1mg/500mg/0.2mg Tablet works:

One tablet of Glimiace MV contains 1mg, 500mg, and 0.2mg of three distinct antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimiace MV 1mg/500mg/0.2mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimiace MV 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimiace MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimiace MV 1mg/500mg/0.2mg tablets in patients with kidney disease carries a high risk and should be strictly avoided. Medical advice from a physician is essential. This medication is particularly unsuitable for individuals with severely impaired kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Glimiace MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimiace MV 1mg/500mg/0.2mg Tablet :

Should you forget to take your Glimiace MV 1mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimiace MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimiace MV 1mg/500mg/0.2mg Tablet

Glimiace MV 1mg/500mg/0.2mg Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Glimiace MV 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Glimiace MV 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any component, those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Glimiace MV 1mg/500mg/0.2mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimiace MV 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimiace MV 1mg/500mg/0.2...
86
MRP 99
13% off